MICROMET
Micromet is a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment and control of cancer. Their lead product candidate, Canvaxin, is one of a new class of products being developed in the area of specific active immunotherapy, also known as therapeutic cancer vaccines.
MICROMET
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
1993-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.cancervax.com
Status:
Closed
Contact:
+490898952770
Total Funding:
146.5 M USD
Current Advisors List
Stock Details
Investors List
Index Ventures
Index Ventures investment in Post-IPO Equity - Micromet
Merlin Nexus
Merlin Nexus investment in Post-IPO Equity - Micromet
NGN Capital
NGN Capital investment in Post-IPO Equity - Micromet
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - Micromet
Abingworth
Abingworth investment in Post-IPO Equity - Micromet
Vector Fund Management
Vector Fund Management investment in Series C - Micromet
JPMorgan Partners
JPMorgan Partners investment in Series C - Micromet
Amerindo Investment Advisors
Amerindo Investment Advisors investment in Series C - Micromet
Forward Ventures
Forward Ventures investment in Series C - Micromet
SV Health Investors
SV Health Investors investment in Venture Round - Micromet
Official Site Inspections
http://www.cancervax.com Semrush global rank: 5.35 M Semrush visits lastest month: 1.56 K
- Host name: cloudproxy10113.sucuri.net
- IP address: 192.124.249.113
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Micromet"
CancerVax - Wikipedia
CancerVax was an American pharmaceutical company founded in 1998 by Donald Morton. The company sought to develop a vaccine for cancer, and had candidates for melanoma reach phase III clinical trials. When those trials proved unsuccessful in 2005, the company soon underwent a reverse takeover with … See moreSee details»
CancerVax Lands Top Cancer Expert - Yahoo Finance
Nov 19, 2024 · CancerVax, Inc. is a pre-clinical biotechnology company developing a novel Universal Cancer Treatment platform that will be customizable, as an injection, to treat many …See details»
CancerVAX Biotech - Chief Executive Officer - LinkedIn
CancerVax is a pre-clinical biotech company developing a novel Universal Cancer Treatment platform that will be customizable, as an injection, to… We are focused on changing the world! …See details»
CancerVAX Company Profile 2024: Valuation, Funding & Investors
Operator of a pre-clinical biotechnology firm intended to develop immunotherapy cancer treatments that use the body's immune system to fight cancer.See details»
Evolution of Cancer Vaccines—Challenges, Achievements, and …
In this review, we address the main antigens and delivery methods used to develop cancer vaccines, their clinical outcomes, and the new directions that the vaccine immunotherapy field …See details»
SCIENTIST AT WORK: DONALD MORTON; Cancer Pioneer Aims To …
Aug 19, 2003 · CancerVax, a company he helped to found, is running two late-stage clinical trials of his vaccine for melanoma.See details»
CancerVax Adds Key Members to Its Research Team - Morningstar
Aug 1, 2024 · Working with a team of world class cancer researchers and practicing oncologists at UCLA, we are developing a breakthrough Universal Cancer Treatment platform that will …See details»
Technology evaluation: Canvaxin, John Wayne Cancer …
CancerVax and the John Wayne Cancer Institute are co-developing Biotechnology Tumor antigen Canvaxin, a vaccine containing over 20 tumor antigens, for the potential treatment of …See details»
CancerVax Files New Patent for Its Novel Universal Cancer …
Aug 27, 2024 · CancerVax is a pre-clinical biotech company developing a novel Universal Cancer Treatment platform that will be customizable, as an injection, to treat many types of cancer. …See details»
CancerVax Lands Top Cancer Expert - Markets Insider
Nov 19, 2024 · CancerVax, Inc. is a pre-clinical biotechnology company developing a novel Universal Cancer Treatment platform that will be customizable, as an injection, to treat many …See details»
Cancer vaccines could be game changing, but they’re …
Apr 26, 2024 · As there are over 200 types of cancer, vaccines are unlikely to be a solution to beating all cancer types. We desperately need a systemic approach to addressing the complex challenges associated with cancer. Research must …See details»
Turning the corner on therapeutic cancer vaccines | npj Vaccines
Feb 8, 2019 · Recent advances in several areas are rekindling interest and enabling progress in the development of therapeutic cancer vaccines. These advances have been made in target …See details»
Cancer vaccine - Wikipedia
Vaccines that treat existing cancer are known as therapeutic cancer vaccines or tumor antigen vaccines. Some of the vaccines are "autologous", being prepared from samples taken from the …See details»
Cancer vaccines: past, present and future; a review article
In this review, we aim to discuss the past, the present, and the future of cancer vaccines. Immunization has been practiced for hundreds of years starting with the use of snake venom …See details»
CancerVax Lands Top Cancer Expert | The Manila Times
Nov 19, 2024 · CancerVax, Inc. is a pre-clinical biotechnology company developing a novel Universal Cancer Treatment platform that will be customizable, as an injection, to treat many …See details»
Cancer Vaccines and Their Side Effects
Most of us know about vaccines given to healthy people to help prevent infections, such as measles and chicken pox. These vaccines use weakened or killed germs like viruses or …See details»
Cancer vaccines as promising immuno-therapeutics: platforms and …
Mar 18, 2022 · Cancer vaccine stimulates anti-tumor immunity with tumor antigens, which could be delivered in the form of whole cells, peptides, nucleic acids, etc. Ideal cancer vaccines …See details»
CancerVax, an allogeneic tumor cell vaccine, induces specific …
CancerVax can induce measurable humoral and cellular immune responses to tumor-associated antigens in patients with advanced-stage colon cancer. These responses correlate with overall …See details»
Thousands of patients to access trials of personalised cancer …
May 31, 2024 · Today, the NHS announced it has treated its first patient in England with a personalised vaccine against their bowel cancer, in a clinical trial part of NHS England’s new …See details»